-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On TransMedics Group with Overweight Rating, Announces Price Target of $120

Benzinga·10/07/2026 13:21:02
Barclays analyst Christopher Pasquale initiates coverage on TransMedics Group (NASDAQ:TMDX) with a Overweight rating and announces Price Target of $120.